US2015152106A1PendingUtilityA1
Selective bromination of perylene diimides and derivatives thereof under mild conditions
Est. expiryMay 9, 2027(~0.8 yrs left)· nominal 20-yr term from priority
C07D 471/06
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention is directed to novel process for the preparation of regioselective perylenediimides derivatives, specifically mono and dibrominated derivatives.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A perylene-diimide compound represented by the structure of formula 4:
wherein
R 1 and R 2 are the same or different comprising substituted or unsubstituted linear or branched alkyl group, substituted or unsubstituted saturated carbocyclic or heterocyclic ring or aryl;
R 3 is saturated or unsaturated heterocyclic ring; saturated or unsaturated carbocyclic ring, alkyl, alkylene or Z-perylene; and
Z is 1,4 phenyl, aryl, cycloalkyl, heterocycle, olefin, azo, amide, C═N, N═C, carbonyl, 1,4 divinylbenzene, piperidine; and
optionally a metal or a metal ion is coordinated to said perylene diimide compound forming a metal complex with said compound.
2 . The compound of claim 1 , wherein said metal or metal ion comprises Pd, Pt, Fe, Cu, Ag, Rh, Ir, Ru or Os.
3 . The compound of claim 1 , wherein said compound is represented by the structure of compound 5:
4 . The compound of claim 1 , wherein said compound is represented by the structure of compound 6:
8 . The compound of claim 1 , wherein said compound is represented by the structure of compound 9:
9 . The compound of claim 1 , wherein said compound is represented by the structure of compound 10:
10 . The compound of claim 1 , wherein said compound is represented by the structure of compound 13:
11 . The compound of claim 1 , wherein said compound is represented by the structure of compound 16:Join the waitlist — get patent alerts
Track US2015152106A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.